Skip to navigation Skip to content

Participate in a Clinical Trial

Without the participation of people with MS, it would be impossible to develop new and better therapies and other interventions.

Clinical Trials in MS


The latest clinical research in MS, including trials funded by the Society and trials in progressive MS.

Read more

Read more

Posting a Trial

If you would like us to post a study on these pages, please email studies@nmss.org to find out what information you need to submit for review.

Share

NOTE: The COVID-19 pandemic may affect the status of the studies listed on this website. Trial recruitment or visits may be postponed, and responses from study coordinators may be delayed. If you are enrolled in a study, your study coordinator will likely reach out to you with any changes. Learn what you need to know about COVID-19

Clinical trials help to determine if treatments are safe and effective. Studies are monitored to ensure that the rights and safety of all participants are protected. Make an informed decision before agreeing to participate. Read more in our Guide to Participating in Clinical Trials.

Clinical Trials In Your Area

Interested in clinical trials? Simply search by state, type of MS or keyword and see what’s going on in your area.

  1. Clinical Trial: H.P. Acthar Gel®

    Investigators are recruiting 66 people with relapsing-remitting MS who have had a relapse and did not experience recovery from the relapse after high-dose intravenous or oral steroids. This study aims to determine the safety and effectiveness of H.P. Acthar Gel® (repository co...

    Get Details

  2. Clinical Trial: Suvorexant for Fatigue and Insomnia

    The MS Center at EvergreenHealth is conducting a randomized, double-blind, placebo-controlled, cross-over trial to assess the safety, tolerability, and efficacy of suvorexant (Belsomra®) in treating insomnia in adults with multiple sclerosis (MS) and fatigue. This study will a...

    Get Details

  3. Clinical Trial: Immune Phenotype Biomarkers After Treatment With Fingolimod

    The MS Center at EvergreenHealth is conducting a study of immune phenotype biomarkers in patients with Relapsing Multiple Sclerosis (RMS) after treatment with 0.5mg fingolimod. This study uses a two-cohort, nonrandomized, open-label, multicenter design. The study consists of t...

    Get Details

  4. Clinical Trial: A Low-Fat Diet for Fatigue in MS

    Dr. Vijayshree Yadav, a neurologist at Oregon Health & Science University, is conducting a study to see if following a low fat diet can help decrease fatigue in people with multiple sclerosis. We are looking for individuals 18-70 years old who are not already following a low-f...

    Get Details

  5. Clinical Trial: Treatment Strategies to Prevent Disability

    A study based at Johns Hopkins University is comparing two treatment strategies in 900 people newly diagnosed, or with onset/diagnosis in the past who have received minimal or no treatment, with the relapsing-remitting form of MS. The study is recruiting at approximately 45 ce...

    Get Details

  6. Clinical Trial: Opicinumab (BIIB033)

    The objective of this study is to evaluate the efficacy and safety of BIIB033 used as add-on therapy to anti-inflammatory disease-modifying therapies (DMTs) in subjects with relapsing multiple sclerosis (RMS). BIIB033 is human monoclonal antibody directed against the LINGO-1 p...

    Get Details

  7. Clinical Trial: Gaze and postural stability in persons with MS

    The objective of the study is to understand vision and balance stability and prevent falls in clinical populations. We want to understand how people stabilize their vision and posture during head and body movement and how treatment (exercise based training) may improve these s...

    Get Details

  8. Clinical Trial: Arbaclofen extended release tablets

    This is a study to evaluate the safety and tolerability of oral arbaclofen extended release tablets in patients with spasticity due to MS. 

    Get Details

  9. Clinical Trial: Spasticity Management Program

    Participants will be placed randomly into one of two groups and will receive one of two different spasticity management programs. Each program consists of education and exercise training intended to help reduce spasticity. All participants will attend two 2-hour group se...

    Get Details

  10. Clinical Trial: Online program to increase physical activity

    Are you over 18 years old with an MS diagnosis (no flare ups in the last 30 days), exercise for 30 minutes or more at least 2 days per week for the last 6 months and would you like to help others with MS be more physically active? The Health Promotion and Rehabilitation Lab (p...

    Get Details

    11.  |<  <  1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 - 10  >  >| 

Share

Learn About Clinical Trials

Discover More

Here are a few related topics that may interest you

Being There - MS Clinical Trials as Experienced by Some Volunteers (.pdf)

Download Document

Clinical Trial Resources

Learn More

MS Trial Alerts

Learn More

Clinical Trial FAQs

Learn More

Placebo Response

Learn More

Past Research Efforts

Learn More

How We Fund Research - NOW Campaign

Learn More

Ending the Disease Forever

Learn More

Restoring What's Been Lost

Learn More

Stopping MS In Its Tracks

Learn More

How and Why Do Scientists Share Results

Learn More

CCSVI

Learn More

Vitamin D

Learn More

Diet

Learn More

Research News

Learn More

Participate in Genetic Studies

Learn More

The National MS Society is Here to Help

Need More Information?

We Are Here

Our MS Navigators help identify solutions and provide access to the resources you are looking for. Call 1-800-344-4867 or contact us online.

Contact Us

Contact Us
Newly Diagnosed
If you or somone close to you has recently been diagnosed, access our MS information and resources.

Start Here

Start Here